CancerIQ

Data shows CancerIQ Reach closes gap between eligibility and participation in payer-supported, standard and supplemental screenings, leads to early cancer diagnoses and promotes health system loyalty story.cd/AAYYMz

ICYMI: July's highlight was our webinar with @NebraskaMed's Cancer Survivorship & Risk & Prevention Director Rachael Schmidt, APRN: "What is Campaign-Based Risk Assessment & How Does It Drive Cancer Screening Compliance?" bit.ly/4d8g9wz #precisionprevention #lungcancer

Beyond traditional clinic settings, there lies a vast opportunity to connect with individuals who might not be aware of their cancer risk or precision prevention opportunities. Learn more about CancerIQ's campaign-based screening: bit.ly/3KlUt3e #precisionprevention

Congratulations to our #CASTUS portfolio company, @CancerIQ, for being named one of the World's Best Digital Health Companies in 2024 by @Newsweek and @StatistaCharts! 🎉 Read full article: bit.ly/4b6tdBH #ClevelandAvenue #NewsWeek #AheadOfCancer

CancerIQ seeks health system participants in large-scale research effort: "Validating Applications for Long-term Utility and Enhanced ROI" (VALUE) in Cancer Risk Programs Study, to document the ROI of digital interventions for genetically informed care. bit.ly/44dbRjP

For #LynchSyndromeAwarenessDay this is your reminder that: 💠 Lynch syndrome is common (1:279 individuals) 💠 Lynch syndrome is actionable (increased surveillance/prevention options lead to better outcomes) 💠 Lynch syndrome is underdiagnosed (most people are not aware that they have it) #ColorectalCancerAwarenessMonth

There's nothing sweeter than saving lives through #precisionprevention, #earlydetection, and treatment! Happy Valentine's Day from team CancerIQ to every provider using genetic information to empower patients and get #aheadofcancer! Learn more: bit.ly/3woogEM

CancerIQ believes that everyone, regardless of where they live, deserves the chance to prevent, detect & treat cancer effectively. Help us make our mission a reality by joining our team. bit.ly/49cNpk6 #WorldCancerDay #CloseTheCareGap #AheadOfCancer #PrecisionPrevention

Q&A: Partnering with providers for #cancer #prevention - @CancerIQ provides personalized care plans to help providers detect cancer early and prevent progression of the disease, says Feyi Ayodele, founder and CEO of CancerIQ. mobihealthnews.com/news/qa-partne…

The American Cancer Society Cancer Facts & Figures 2024 report is here. With breast, prostate, colorectal (ages 0-54), and cervical (ages 30-44) cancers on the rise, it's important to get screened. Hear more from @AmerCancerCEO. Full report: amercancer.co/cff24

A much larger pool of patients now requires access to #genetictesting given @ASCO's expanded BRCA1/2 mutation testing recommendations for all #bscm patients <65 years old. It's imperative we equip clinical teams with the tools to support increased volumes. bit.ly/48E6dbU

New germline genetic testing guidelines: All women with breast cancer diagnosis under the age of 65 should be offered germline genetic testing. They don’t need to meet any additional criteria. Thank you @ASCO for the opportunity to draft these guidelines. ascopubs.org/doi/full/10.12…

Happy, Healthy New Year 2024 from all of us at CancerIQ! Together, we can stay ahead of cancer, bringing hope and health to our communities. Here's to a year of breakthroughs, health, and progress! #aheadofcancer #precisionprevention

1/ Welcome to #CGAIGCJS November Tweetorial on the Making #Genetic Testing Accessible (MAGENTA) Trial by #CGAIGC Comms Cttee member @asafmaoz ➡️The full article from @JAMAOnc can be found at 👉tinyurl.com/bdh5t6jv 🧵 #HereditaryGICancer

.@CancerX is conducting its first demonstration project to merge data assets, and collaborating with industry partners (including @CancerIQ!) to build comprehensive real-world datasets in a way that’s never been done before in oncology. Learn more: bit.ly/3tmfxlt

A new study co-authored by @CatharineWang, @BUSPH and Haibo Lu, @CancerIQ shows point-of-care genetics may improve access, uptake, and reduce racial disparities across broad patient populations. #SABCS23 #BCSM #GeneChat bit.ly/4a9utny

We're thrilled to announce @AssuranceLab SOC 2 Type 2 Compliance, demonstrating that we have undergone rigorous testing & are a trusted platform for empowering health systems to scale genetically informed cancer prevention, treatment, & survivorship care. prweb.com/releases/cance…

Patient advocate @ARosen380 at @AmericanCancer shares her story & the importance of a #precisionprevention approach for high-risk patient management: "Having Crohn’s disease put me at greater risk for colorectal cancer & as a result, every year, I have a diagnostic colonoscopy."

Today is #GeneticCounselorAwarenessDay! At CancerIQ, we are grateful for the essential role cancer genetic counselors play in helping patients precisely treat, predict, pre-empt, and prevent this disease. bit.ly/3FTl1He #GeneChat #AheadOfCancer #PrecisionPrevention

When the #BreastCancerAwarenessMonth pink is packed away, many women don't think about their prevention plans again until next year. Learn how CancerIQ can help you identify, assess, & manage the high-risk patients that need more than an annual screening. bit.ly/3SyqVVv